ORIC Pharmaceuticals stockORIC
ORIC Pharmaceuticals trades at $8.49, 42.2% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. +3.8% year to date, −31.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for ORIC — after you log in
Open the terminalFrequently asked questions about ORIC Pharmaceuticals
What is the ORIC Pharmaceuticals stock price?
At the close on Nov 5, 2026: $8.49 (−9.10% on the day). 52-week high: $14.68 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does ORIC Pharmaceuticals report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed +19% year over year, revenue 0%.
Does ORIC Pharmaceuticals pay dividends?
No, ORIC Pharmaceuticals does not pay dividends.
Where does ORIC Pharmaceuticals trade and how to buy it?
Ticker ORIC, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy ORIC Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ORIC are in the terminal after you log in.